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Non-melanoma skin cancer (NMSC) have been 
mostly found among the Caucasian people (1, 2) 
This type of cancer is basically divided into two 
parts, i.e. Basal cell carcinoma (BCC) and Squamous 
cell carcinoma (SCC)(3, 4). The mortality rate is 
usually low in this case (1). A major molecular 
factor involved in the disease process is the mutation 
in gene PTCH1 that plays an important role in the 
Sonic hedgehog signaling pathway (5, 6). PTCH1 
has a deterrence role for SMO and when SMO is not 
inhibited GLI (7), as a transcription factor, is 
activated (6). But, factors such as age, exposure to 
UV, positive family history, male gender, genetic 
predisposition as well as skin color (Caucasians)  
Non-melanoma skin cancer (NMSC) has been frequently found 
in Caucasians. Basically, this type of cancer is divided into two 
parts, i.e. (BCC and SCC). Mutation in gene PTCH1 is one of 
the molecular causes involved in the disease process that plays 
an important role in the Sonic hedgehog signaling pathway, but 
the factors involving in the creation of NMCS are the ones 
such as age, exposure to UV ray, positive family history, male 
gender, genetic predisposition as well as skin color 
(Caucasians). In the therapeutic terms, surgery is considered as 
the best treatment although Radiotherapy and Cryotherapy are 
also used to treat but surgery is the gold standard of treatment. 
Immune therapy is also a new method of treatment for NMCS. 
In this paper, we have provided the treatment methods and 
have suggested the best treatment method through multiple 
studies.  
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have a major role in creating NMCS (8, 9). The main 
factor of catching to NMSC deemed to be UV light 
of course when linked and immunosuppression (10, 
11)but occurs during transplantation and 
immunosuppression, too. So, we can conclude that 
people infected with HIV virus are more likely to 
develop the disease symptoms (12, 13) By xeno-
engraftment of human primary SCC cells, the 
presence of cancer cells has been confirmed in stem 
cells or tumor initiating (14, 15). Since the stem cells 
exist in the epidermis for a long time, so they have 
the capability necessary to start the tumors due to the 
genetic errors (15, 16). Β-Catenin, existing in the 
signaling pathway, is an example of a signaling 
pathway that controls the fate of the stem cells as 
well as the phenotype NMSC (17, 18).  In terms of 
treatment, surgery is the best treatment method (19, 
20), however, we can use radiotherapy, too (21). Of 
course, radiotherapy plays an important role in 
treatment up to 90% (22). Cryotherapy is also used 
to treat but the gold standard method of treatment is 
surgery (20, 23, 24). In addition, Photodynamic 
Therapy (PDT) has been used in England and have 
had favorable effects (25, 26).  
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If we are going to have a look in new NMSC 
treatment methods, so we can point out the immune-
therapy in which, the treatment is done by inducing 
the production of cytokines and chemokines from 
dendritic cells and monocytes, whoever, it is not so 
common (27). On the other hand, the current 
molecular studies on the gene SMO will bring new 
hopes and possibilities in terms of the future 
treatments (28). 
Chemicals found in cigarette smoke are considered 
as the very important factors in catching this kind of 
cancer (29) and increases the risk of cancer in SCC, 
significantly (30).The other chemicals including 
arsenic are also considered very important in 
developing the NMSC (31–33). Arsenic suppresses 
the ATP production and subsequently, the DNA 
healing mechanisms, having a serious dependence 
on the energy, become inefficient (33). The next 
important factor is vitamin D leading to lower 
incidence of NMSC (34–37). Through different 
methods like suppression of angiogenesis and 
apoptosis induction and by vitamin B3, as well, we 
can exemplify nicotinic-amide contributing in 
energizing and, as mentioned previously, the DNA 
repair system depends on ATP (38). Recent 
researches show that HPV may contribute to this 
type of cancer (39). There are more than 120 types 
of human papillomavirus that involve the skin and 
mucous membrane(40); in particular, the gene E6 
that damages the protein P53 and subsequently, the 
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gene E6 that damages the protein P53 and 
subsequently, the apoptosis and the  DNA healing 
will be faced to the problem  (41) that leads to 
NMSC (39). 
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Figur1(42): The effect of UV radiation on the skin (carcinogenesis by UV radiation) 
 
method  Effect 
 Surgery  Gold Standard(13) 
Radiotherapy 90%(15) 
 Cryotherapy  Limited (12) 
PDT Favorable (16) 
 Immune therapy  5%In Europe(12) 
Table 1. Current treatment methods and their effects  
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Conclusion 
In terms of treatment, surgery is considered to be the best treatment method, although radiotherapy can be 
used, too, and of course, radiotherapy plays an important and useful role in up to 90% of the cases. 
Cryotherapy is also used to treat. As two of the newest NMSC treatment methods, Photodynamic Therapy 
(PTD) and Immune therapy can be pointed out, but the gold standard treatment is surgery. 
 Kormi and Ardehkhani 2017. The Cancer Press, 3(1): 17-21                                                                                                                 21 
Figur2: Comparison between three current methods of treatment 
